Drugs & Aging

, Volume 21, Issue 12, pp 793–811

Medication Non-Adherence in the Elderly

How Big is the Problem?
Review Article


Adherence to medication is one of the most intriguing and complex behaviours demonstrated by patients. Non-adherence to a therapeutic regimen may result in negative outcomes for patients and may be compounded in populations with multiple morbidities which require multiple drug therapy. Such a population is exemplified by the elderly. However, non-adherence may not be more prevalent in older patients and there is no consensus in the literature that age is a predictor of poor adherence. Indeed, older patients may deliberately choose not to adhere to medication (intentional non-adherence) to avoid adverse effects. Furthermore, many of the studies on adherence lack commonality in terms of how adherence is measured, the definition of an ‘older’ patient and the range of disease states which have been examined. Adherence may also be affected by access to medications which may be restricted by the use of formularies or insurance programmes. However, non-adherence may represent a greater risk in older people resulting in poor disease control which may be compounded with multiple morbidity and polypharmacy.

A range of strategies have been implemented to try and improve adherence in this patient population. The use of forgiving drugs (those which have a prescribed dosage interval that is 50% or less the duration of drug action) may facilitate occasional lapses in drug-taking. Drug holidays (deliberate, supervised non-adherence for a fixed period of time) have been used in Parkinson’s disease to reduce adverse effects. Once-daily scheduling of drug administration may offer a pragmatic approach to optimising drug therapy in some patients; this may be supplemented through the use of compliance aids. What is increasingly apparent, however, is that the role of the patient (irrespective of age) is critical in decision-making about medication, together with communication between patients and healthcare professionals. This has been articulated through the concept of concordance which has been described as a therapeutic alliance between the patient and healthcare professional. In addition, interventions employed to improve adherence must be multifaceted, and together with practical approaches (reducing unnecessary drugs and simplifying dosage regimens), the patient perspective must be considered. Good adherence should be seen as a means of achieving a satisfactory therapeutic result and not as an end in itself.


  1. 1.
    Haynes RB. Determinants of compliance: the disease and the mechanics in treatment. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in health care. Baltimore (MD): Johns Hopkins University Press, 1979: 3–18Google Scholar
  2. 2.
    Schaffer SD, Yoon S-JL. Evidence-based methods to enhance medication adherence. Nurse Pract 2001; 26: 50–4CrossRefGoogle Scholar
  3. 3.
    Haynes RB, Matteson ME, Garrity TF, et al. Management of patient compliance in the treatment of hypertension. Hypertension 1982; 4: 415–23CrossRefGoogle Scholar
  4. 4.
    Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67–74PubMedCrossRefGoogle Scholar
  5. 5.
    World Health Organisation (WHO). Adherence to long-term therapies: evidence for action. Geneva: WHO, 2003Google Scholar
  6. 6.
    From compliance to concordance: achieving shared goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain and Merck Sharp & Dohme, 1997Google Scholar
  7. 7.
    Jones G. Prescribing and taking medicines. BMJ 2003; 327: 819–20PubMedCrossRefGoogle Scholar
  8. 8.
    Noncompliance with medications: an economic tragedy with important implications for health care reform. Baltimore (MD): The Task Force for Compliance, 1993Google Scholar
  9. 9.
    Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 1991; 48: 1978–88PubMedGoogle Scholar
  10. 10.
    Wright EC. Non-compliance or how many aunts has Matilda? Lancet 1993; 342: 909–13PubMedCrossRefGoogle Scholar
  11. 11.
    Morris LS, Schulz RM. Patient compliance: an overview. J Clin Pharm Ther 1992; 17: 283–95PubMedCrossRefGoogle Scholar
  12. 12.
    Salzman C. Medication compliance in the elderly. J Clin Psychiatry 1995; 56Suppl. 1: 18–23PubMedGoogle Scholar
  13. 13.
    Donovan JL. Patient decision making: the missing ingredient in compliance research. Int J Technol Assess Health Care 1995; 11: 443–55PubMedCrossRefGoogle Scholar
  14. 14.
    Morris LS, Schulz RM. Medication compliance: the patient’s perspective. Clin Ther 1993; 15: 593–606PubMedGoogle Scholar
  15. 15.
    Nichol MB, Venturini F, Sung JCY. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother 1999; 33: 531–40PubMedCrossRefGoogle Scholar
  16. 16.
    Grymonpre RE, Didur CD, Montgomery PR, et al. Pill count, self-report and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 1998; 32: 749–54PubMedCrossRefGoogle Scholar
  17. 17.
    Sturgess IK, Hughes CM, McElnay JC, et al. Identifying non-compliance of elderly patients: a comparison of three methods. Pharm J 1998; 261: R14Google Scholar
  18. 18.
    Burnier M, Schneider MP, Chiolero A, et al. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001; 19: 335–41PubMedCrossRefGoogle Scholar
  19. 19.
    Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol 1993; 72: 68–74DCrossRefGoogle Scholar
  20. 20.
    Raynor DK. Patient compliance: the pharmacist’s role. Int J Pharm Pract 1992; 1: 126–35CrossRefGoogle Scholar
  21. 21.
    Conner M, Norman P. The role of social cognition in health behaviours. In: Conner M, Norman P, editors. Predicting health behaviour. Buckingham: Open University Press, 1996Google Scholar
  22. 22.
    Rosenstock I. Why people use health services. Milbank Mem Fund Q 1966; 44: 94–124PubMedCrossRefGoogle Scholar
  23. 23.
    Becker MH. The health belief model and sick role behaviour. Health Educ Monogr 1974; 2: 409–19Google Scholar
  24. 24.
    Wallston KA. Hocus-pocus, the focus isn’t strictly on locus: Rotter’s social learning theory modified for health. Cognit Ther Res 1992; 16: 183–99CrossRefGoogle Scholar
  25. 25.
    Bandura A. Self-efficacy: towards a unifying theory of behavioural change. Psychol Rev 1977; 84: 191–215PubMedCrossRefGoogle Scholar
  26. 26.
    Fishbein M, Ajzen I. Belief, attitude, intention and behaviour: an introduction to theory and research. New York: Wiley, 1975Google Scholar
  27. 27.
    Azjen I. Attitudes, personality and behaviour. Milton Keynes: Open University Press, 1988Google Scholar
  28. 28.
    Conrad P. The meaning of medications: another look at compliance. Soc Sci Med 1985; 20: 28–37CrossRefGoogle Scholar
  29. 29.
    Costa Jr PT, McCrae RR. The NEO personality inventory-R: professional manual. Odessa (FL): Psychological Assessment Resources, 1992Google Scholar
  30. 30.
    Christensen AJ, Smith TW. Personality and patient adherence: correlated of the Five-Factor model in renal dialysis. J Behav Med 1995; 18: 305–13PubMedCrossRefGoogle Scholar
  31. 31.
    Stewart RB, Caranasos GJ. Medication compliance in the elderly. Med Clin North Am 1989; 73: 1551–63PubMedGoogle Scholar
  32. 32.
    Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998; 20: 764–71PubMedCrossRefGoogle Scholar
  33. 33.
    Weintraub M. Intelligent non-compliance with special emphasis on the elderly. Contemp Pharm Pract 1980; 4: 8–11Google Scholar
  34. 34.
    Melnikow J, Kiefe C. Patient compliance and medical research: issues in methodology. J Gen Intern Med 1994; 9: 96–105PubMedCrossRefGoogle Scholar
  35. 35.
    Mallion JM, Baguet JP, Siche JP. Compliance, electronic monitoring and antihypertensive drugs. J Hypertens 1997; 16Suppl. 1: S75–80Google Scholar
  36. 36.
    Park DC, Morrell RW, Frieske D, et al. Medication adherence behaviours in older adults: effects of external cognitive supports. Psychol Aging 1992; 7: 252–6PubMedCrossRefGoogle Scholar
  37. 37.
    Shalansky SJ, Levy AR. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother 2002; 36: 1532–9PubMedCrossRefGoogle Scholar
  38. 38.
    Gao X, Nau DP, Rosenbluth SA, et al. The relationship of disease severity, health beliefs and medication adherence among HIV subjects. AIDS Care 2000; 12: 387–98PubMedCrossRefGoogle Scholar
  39. 39.
    Billups SJ, Malone DC, Carter BL. The relationship between drug therapy non-compliance and patient characteristics, health-related quality of life and healthcare costs. Pharmacotherapy 2000; 20: 941–9PubMedCrossRefGoogle Scholar
  40. 40.
    Farmer KC, Jacobs EW, Phillips CR. Long-term patient compliance with prescribed regimens of calcium channel blockers. Clin Ther 1994; 16: 316–26PubMedGoogle Scholar
  41. 41.
    Spiers MV, Kutzik DM. Self-reported memory of medication use by the elderly. Am J Health Syst Pharm 1995; 52: 985–90PubMedGoogle Scholar
  42. 42.
    Cline CMJ, Bjorck-Linne AK, Israelsson BYA, et al. Noncompliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail 1999; 1: 145–9PubMedCrossRefGoogle Scholar
  43. 43.
    Monane M, Bohn RL, Gurwitz JH, et al. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994; 154: 433–7PubMedCrossRefGoogle Scholar
  44. 44.
    Jones JK, Gorkin L, Lian JF. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995; 311: 293–5PubMedCrossRefGoogle Scholar
  45. 45.
    Morrell RW, Park DC, Kidder DP, et al. Adherence to antihypertensive medications across the life span. Gerontologist 1997; 37: 609–19PubMedCrossRefGoogle Scholar
  46. 46.
    Richardson MA, Simons-Morton B, Annegers JF. Effect of perceived barriers on compliance with antihypertensive medication. Health Educ Q 1993; 20: 489–503PubMedCrossRefGoogle Scholar
  47. 47.
    Lau HS, Beuning KS, Postma-Lim E, et al. Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis. Pharm World Sci 1996; 18: 63–8PubMedCrossRefGoogle Scholar
  48. 48.
    Owen SG, Friesen WT, Roberts MS, et al. Determinants of compliance in rheumatoid arthritic patients assessed in their home environment. Br J Rheumatol 1985; 24: 313–20PubMedCrossRefGoogle Scholar
  49. 49.
    Park DC, Hertzog C, Leventhal H, et al. Medication adherence in rheumatoid arthritis patients: older is wiser. J Am Geriatr Soc 1999; 47: 172–83PubMedGoogle Scholar
  50. 50.
    Viller F, Guillemin F, Briancon S, et al. Compliance to drug treatment of patients rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol 1999; 26: 2114–22PubMedGoogle Scholar
  51. 51.
    Curtin RB, Svarstad BL, Andress D, et al. Differences in older versus younger hemodialysis patients’ non-compliance with oral medications. Geriatr Nephrol Urol 1997; 7: 35–44PubMedCrossRefGoogle Scholar
  52. 52.
    Brewer NT, Chapman GB, Brownlee S, et al. Cholesterol control, medication adherence and illness cognition. Br J Health Psychol 2002; 7: 433–47PubMedCrossRefGoogle Scholar
  53. 53.
    Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288: 455–61PubMedCrossRefGoogle Scholar
  54. 54.
    Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288: 462–7PubMedCrossRefGoogle Scholar
  55. 55.
    Hulka BS, Cassel JC, Kupper LL, et al. Communication, compliance and concordance between physicians and patients with prescribed medications. Am J Public Health 1976; 66: 846–53Google Scholar
  56. 56.
    Dolce JJ, Crisp C, Manzella B, et al. Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991; 99: 837–41PubMedCrossRefGoogle Scholar
  57. 57.
    Carney RM, Freedland KE, Eisen SA, et al. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995; 14: 88–90PubMedCrossRefGoogle Scholar
  58. 58.
    DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for non-compliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101–7PubMedCrossRefGoogle Scholar
  59. 59.
    Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 1987; 35: 539–45CrossRefGoogle Scholar
  60. 60.
    Soumerai SB, Avorn J, Ross-Degnan D, et al. Payment restrictions for prescription drugs under Medicaid: effects on therapy, costs and equity. N Engl J Med 1987; 317: 550–6PubMedCrossRefGoogle Scholar
  61. 61.
    Soumerai SB, Ross-Degnan D, Avorn J, et al. Effects of Medicaid drug payment limits on admission to hospitals and nursing homes. N Engl J Med 1991; 325: 1072–7PubMedCrossRefGoogle Scholar
  62. 62.
    Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effects of limiting Medicaid drug reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1997; 331: 650–5CrossRefGoogle Scholar
  63. 63.
    Bazargan M, Barbre AR, Hamm V. Failure to have prescriptions filled among black elderly. J Aging Health 1993; 5: 264–82PubMedCrossRefGoogle Scholar
  64. 64.
    Malhotra S, Karan RS, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703–7PubMedCrossRefGoogle Scholar
  65. 65.
    Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841–5PubMedCrossRefGoogle Scholar
  66. 66.
    McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. Arch Intern Med 1997; 157: 1921–9PubMedCrossRefGoogle Scholar
  67. 67.
    Horwitz RI, Viscoli CM, Berkman L, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336: 542–5PubMedCrossRefGoogle Scholar
  68. 68.
    Cramer JA. Optimizing long-term patient compliance. Neurology 1995; 45Suppl. 1: S25–8PubMedGoogle Scholar
  69. 69.
    Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta analysis. Med Care 1998; 36: 1138–61PubMedCrossRefGoogle Scholar
  70. 70.
    Urquhart J. Partial compliance in cardiovascular disease: risk implications. Br J Clin Practice Suppl 1994; 73: 2–12Google Scholar
  71. 71.
    Stephenson BJ, Rowe BH, Haynes RB, et al. Is this patient taking the treatment as prescribed? JAMA 1993; 269: 2779–81PubMedCrossRefGoogle Scholar
  72. 72.
    Urquhart J. Patient compliance with crucial drug regimens: implications for prostate cancer. Eur Urology 1996; 29Suppl. 2: 124–31Google Scholar
  73. 73.
    Haynes RB, Gibson ES, Taylor DW, et al. Process versus outcome in hypertension: a positive result. Circulation 1982; 65: 28–33PubMedCrossRefGoogle Scholar
  74. 74.
    Markowitz M. Eradication of rheumatic fever: an unfulfilled hope. Circulation 1970; 41: 1077–84PubMedCrossRefGoogle Scholar
  75. 75.
    Mallion JM, Dutrey-Dupagne C, Vaur L, et al. Benefits of electronic pillboxes in evaluating treatment compliance of patient with mild to moderate hypertension. J Hypertens 1996; 14: 137–44PubMedGoogle Scholar
  76. 76.
    Rudd P, Ahmed S, Zachary V, et al. Issues in patient compliance: the search for therapeutic sufficiency. Cardiology 1992; 80Suppl. 1: 2–10PubMedCrossRefGoogle Scholar
  77. 77.
    Feldman RG, Kaye JA, Lannon MC. Parkinson’s disease: follow-up after ‘drug holiday’. J Clin Pharmacol 1985; 26: 662–7Google Scholar
  78. 78.
    Bermejo F, Calandre L. Molina JA, et al. Long-lasting drug holiday in Parkinson’s disease. Adv Neurol 1986; 45: 503–6Google Scholar
  79. 79.
    Mayeux R, Stern Y, Mulvey K, et al. Reappraisal of temporary levodopa withdrawal (‘drug holiday’) in Parkinson’s disease. N Engl J Med 1985; 313: 124–38CrossRefGoogle Scholar
  80. 80.
    Corona T, Rivera C, Otero E, et al. A longitudinal study of the effects of an l-dopa drug holiday in the course of Parkinson’s disease. Clin Neuropharmacol 1995; 18: 325–32PubMedCrossRefGoogle Scholar
  81. 81.
    Steinberg SK. Considerations in the implementation of drug holiday programs in long-term care facilities. Can Pharm J 1984; 117: 214–6PubMedGoogle Scholar
  82. 82.
    Cramer JA. Enhancing patient compliance in the elderly: role of packaging aids and monitoring. Drugs Aging 1998; 12: 7–15PubMedCrossRefGoogle Scholar
  83. 83.
    Hyland ME. Rationale for once-daily therapy in asthma: compliance issues. Drugs 1999; 58Suppl. 4: 1–6PubMedCrossRefGoogle Scholar
  84. 84.
    Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003; 326: 1419–24PubMedCrossRefGoogle Scholar
  85. 85.
    Horne R, Clatworthy J, Polmear A, et al. Do hypertensive patients’ beliefs about their illness and treatment influence medication adherence and quality of life. J Hum Hypertens 2001; 15Suppl. 1: S65–8PubMedGoogle Scholar
  86. 86.
    Wong BSM, Norman DC. Evaluation of a novel medication aid, the calendar blister-pak, and its effect on drug compliance in a geriatric outpatient clinic. J Am Geriatr Soc 1987; 35: 21–6PubMedGoogle Scholar
  87. 87.
    Murray MD, Birt JA, Manatunga AK, et al. Medication compliance in elderly outpatients using twice-daily dosing and unit-of-use packaging. Ann Pharmacother 1993; 27: 616–21PubMedGoogle Scholar
  88. 88.
    Medication and compliance: major issues in elderly patients with mobility problems. Drugs Ther Perspect 2000; 15(6): 5–7Google Scholar
  89. 89.
    Konkle-Parker DJ. A motivational intervention to improve adherence to treatment of chronic disease. J Am Acad Nurse Pract 2001; 13: 61–8PubMedCrossRefGoogle Scholar
  90. 90.
    Willey C. Behavior-changing methods for improving adherence to medication. Curr Hypertens Rep 1999; 1: 477–81PubMedCrossRefGoogle Scholar
  91. 91.
    Van Eijken M, Tsang S, Wensing M, et al. Interventions to improve medication compliance in older patients living in the community. Drugs Aging 2003; 20: 229–40PubMedCrossRefGoogle Scholar
  92. 92.
    Peterson AM, Takiya L, Finley R. Meta-analysis of trails of interventions to improve medication adherence. Am J Health Syst Pharm 2003; 60: 657–65PubMedGoogle Scholar
  93. 93.
    Windsor RA, Bailey WC, Richards JM, et al. Evaluation of the efficacy and cost-effectiveness of health education methods to increase medication adherence among adults with asthma. Am J Public Health 1990; 80: 1519–21PubMedCrossRefGoogle Scholar
  94. 94.
    Hussey RN. Overcoming the clinical barriers of low literacy and medication non-compliance among the elderly. J Gerontol Nurs 1991; 17: 27–9PubMedGoogle Scholar
  95. 95.
    Botelho RJ, Dudrak R. Home assessment of adherence to long-term medication in the elderly. J Fam Pract 1992; 35: 61–5PubMedGoogle Scholar
  96. 96.
    Edworthy SM, Devins GM, and the Patient Education Study Group. Improving medication adherence between appropriate and inappropriate utilization. J Rheumatol 1999; 26: 1793–801PubMedGoogle Scholar
  97. 97.
    Powell KM, Edgren B. Failure of educational videotapes to improve medication compliance in a health maintenance organization. Am J Health Syst Pharm 1995; 52: 2196–9PubMedGoogle Scholar
  98. 98.
    Leirer VO, Morrow DG, Tanke ED, et al. Elders’ nonadherence: its assessment and medication reminding by voice mail. Gerontologist 1991; 31: 514–20PubMedCrossRefGoogle Scholar
  99. 99.
    Patton K, Meyers J, Lewis BE. Enhancement of compliance among patients with hypertension. Am J Managed Care 1997; 3: 1693–8Google Scholar
  100. 100.
    Stamler R, Stamler J, Civinelli J, et al. Adherence and blood pressure response to hypertension treatment. Lancet 1975; II: 1227–30CrossRefGoogle Scholar
  101. 101.
    Russell ML, Isull W, Probstfield JL. Examination of medical professions for counseling on medication adherence. Am J Med 1985; 78: 277–82PubMedCrossRefGoogle Scholar
  102. 102.
    DiMatteo RM, Sherbourne CD, Hays RD, et al. Physicians’ characteristics influence patients’ adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol 1993; 12: 93–102PubMedCrossRefGoogle Scholar
  103. 103.
    Gurwitz JH, Yeomans SM, Glynn RJ, et al. Patient noncompliance in the managed care setting: the care of medical therapy for glaucoma. Med Care 1998; 36: 357–69PubMedCrossRefGoogle Scholar
  104. 104.
    Say RE, Thomson R. The importance of patient preferences in treatment decisions-challenges for doctors. BMJ 2003; 357: 542–5CrossRefGoogle Scholar
  105. 105.
    Jaarsma T, Abu-Saad HH, Dracup K, et al. Self-care behavior of patients with heart failure. Scand J Caring Sci 2000; 14: 112–9PubMedCrossRefGoogle Scholar
  106. 106.
    Dowell J, Jones A, Snadden D. Exploring medication use to seek concordance with ‘non-adherent’ patients: a qualitative study. Br J Gen Pract 2002; 52: 24–32PubMedGoogle Scholar
  107. 107.
    Morse EV, Simon PM, Balson PM. Using experiential training to enhance health professionals’ awareness of patient compliance issues. Acad Med 1993; 68: 693–7PubMedCrossRefGoogle Scholar
  108. 108.
    Garay-Savilla ME, Malacara JM, Gonzalez-Parada F, et al. The belief in conventional medicine and adherence to treatment in non-insulin-dependent diabetes mellitus patients. J Diabetes Complications 1998; 12: 239–45CrossRefGoogle Scholar
  109. 109.
    DiMatteo MR. Patient adherence to pharmacotherapy: the importance of effective communication. Formulary 1995; 30: 596–605PubMedGoogle Scholar
  110. 110.
    Williams GC, Rodin GC, Ryan RM, et al. Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychol 1998; 17: 269–76PubMedCrossRefGoogle Scholar
  111. 111.
    De Young M. Research on the effects of pharmacist-patient communication in institutions and ambulatory care sites, 1969–1994. Am J Health Syst Pharm 1996; 53: 1277–91PubMedGoogle Scholar
  112. 112.
    Bultman DC, Svarstad BL. Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc 2002; 42: 36–43CrossRefGoogle Scholar
  113. 113.
    Kozma CM. Noncompliance with medication therapy: when does it make a difference in outcomes. Manag Care Interface 2002; 15: 30–1PubMedGoogle Scholar
  114. 114.
    Frank E. Enhancing patient outcomes: treatment adherence. J Clin Psychiatry 1997; 58Suppl. 1: 11–4PubMedGoogle Scholar

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  1. 1.School of PharmacyQueen’s University BelfastBelfastNorthern Ireland

Personalised recommendations